Real Evidence and Misconceptions about Malignant Hyperthermia in Children: A Narrative Review
Authors:
- Luciano FrassanitoLuciano Frassanito
- Fabio SbaragliaFSFabio Sbaraglia
- Alessandra PiersantiAPAlessandra Piersanti
- Francesco VassalliFVFrancesco Vassalli
- Monica LucenteMLMonica Lucente
- Nicoletta FileticiNFNicoletta Filetici
- Bruno Antonio ZanfiniBZBruno Antonio Zanfini
- Stefano CatarciSCStefano Catarci
- Gaetano DraisciGDGaetano Draisci
Open Access
- 6 June 2023
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (12) , 3869
Abstract
Malignant hyperthermia is a rare but life-threatening pharmacogenetic disorder triggered by exposure to specific anesthetic agents. Although this occurrence could affect virtually any patient during the perioperative time, the pediatric population is particularly vulnerable, and it has a five-fold higher incidence in children compared to adults. In the last few decades, synergistic efforts among leading anesthesiology, pediatrics, and neurology associations have produced new evidence concerning the diagnostic pathway, avoiding unnecessary testing and limiting false diagnoses. However, a personalized approach and an effective prevention policy focused on clearly recognizing the high-risk population, defining perioperative trigger-free hospitalization, and rapid activation of supportive therapy should be improved. Based on epidemiological data, many national scientific societies have produced consistent guidelines, but many misconceptions are common among physicians and healthcare workers. This review shall consider all these aspects and summarize the most recent updates.Keywords
This publication has 92 references indexed in Scilit:
- Exercise‐Induced Rhabdomyolysis and Stress‐Induced Malignant Hyperthermia Events, Association with Malignant Hyperthermia Susceptibility, and RYR1 Gene Sequence VariationsThe Scientific World Journal, 2013
- Exertional RhabdomyolysisJournal of Clinical Neuromuscular Disease, 2012
- Malignant hyperthermia — Human stress triggeringBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia GroupBritish Journal of Anaesthesia, 2010
- FKBP12 deficiency reduces strength deficits after eccentric contraction-induced muscle injuryJournal of Applied Physiology, 2008
- Temperature Monitoring and Perioperative ThermoregulationAnesthesiology, 2008
- Central core diseaseOrphanet Journal of Rare Diseases, 2007
- Standardization of the Caffeine Halothane Muscle Contracture TestAnesthesia & Analgesia, 1989
- DantroleneDrugs, 1986
- An evaluation of the possible association of malignant hyperpyrexia with the Noonan syndrome using serum creatine phosphokinase levelsThe Journal of Pediatrics, 1975